Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Bierbaumer

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cells|April 25, 2020
The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma PathogenesisHeinrich Kovar, Lisa Bierbaumer, Branka Radic-Sarikas
Tissue Barriers|September 26, 2018
Cell culture models of oral mucosal barriers: A review with a focus on applications, culture conditions and barrier propertiesLisa Bierbaumer, Uwe Yacine Schwarze, Reinhard Gruber, et al.
Oncology Letters|February 14, 2018
Dynamics of CRISPR/Cas9-mediated genomic editing of the <i>AXL</i> locus in hepatocellular carcinoma cellsIrene Scharf, Lisa Bierbaumer, Heidemarie Huber, et al.
Oncogenesis|January 9, 2021
YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cellsLisa Bierbaumer, Anna M Katschnig, Branka Radic-Sarikas, et al.
Cancer Letters|December 3, 2022
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-X<sub>L</sub> inhibition against Ewing sarcomaSarah Grissenberger, Caterina Sturtzel, Andrea Wenninger-Weinzierl, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cells|April 25, 2020
The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma PathogenesisHeinrich Kovar, Lisa Bierbaumer, Branka Radic-Sarikas
Tissue Barriers|September 26, 2018
Cell culture models of oral mucosal barriers: A review with a focus on applications, culture conditions and barrier propertiesLisa Bierbaumer, Uwe Yacine Schwarze, Reinhard Gruber, et al.
Oncology Letters|February 14, 2018
Dynamics of CRISPR/Cas9-mediated genomic editing of the <i>AXL</i> locus in hepatocellular carcinoma cellsIrene Scharf, Lisa Bierbaumer, Heidemarie Huber, et al.
Oncogenesis|January 9, 2021
YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cellsLisa Bierbaumer, Anna M Katschnig, Branka Radic-Sarikas, et al.
Cancer Letters|December 3, 2022
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-X<sub>L</sub> inhibition against Ewing sarcomaSarah Grissenberger, Caterina Sturtzel, Andrea Wenninger-Weinzierl, et al.
Pageof 1